OneMedPlace Now On Twitter and LinkedIn
Follow OneMedPlace on Twitter to discover the latest happenings in the life sciences industry.
feature2
Audiopoint Introduces Phone-Based EHR System
Earlier this month, Audiopoint added its voice to the list of companies developing EHR products.
Melanoma Drug Called a “Breakthrough” After Study
Scientists are calling Plexxikon’s experimental skin cancer drug a “breakthrough” after it successfully shrank tumors in clinical trial patients.
Nasdaq Buoyed by Biotech
The Nasdaq rose 5 points on Monday, due in part to recent happenings in the biopharmaceutical sector.
Potential Breakthrough in Search for AIDS Vaccine
Scientists at the Scripps Research Institute have isolated two antibodies that can prevent patients with HIV from developing severe AIDS.
Heart Failure Society of America Holds Annual Meeting
A roundup of news from the Heart Failure Society of America’s annual meeting.
Seaside Therapeutics Secures $30M to Fight Autism
Seaside Therapeutics has secured $30 million in funding from a private, unnamed family investment firm committed to finding treatments for autism and Fragile X syndrome.
Xenoport Reports Positive Data for Chronic Pain Drug
Most people wouldn’t think that a case of chicken pox could cause chronic pain, but many people across the U.S. feel the effects of this common childhood disease years after the red spots have disappeared.
First Swine Flu Vaccines Approved
The U.S. government has approved swine flu vaccines from four pharmaceutical companies, Reuters reports.
FDA Approves Vermillion’s Ovarian Cancer Test
The U.S. Food and Drug Administration has approved a blood test to detect ovarian cancer and help physicians decide what kind of surgery should be done and by whom.